Huiling Qu
Shida Yang2
Xiaoyu Sun
Huisheng Chen- 1Department of Neurology, The General Hospital of Northern Theater Command, Shenyang, China
- 2Department of Laboratory Medicine, The People's Hospital of Liaoning Province, Shenyang, China
- 3Department of Neurology, The People's Hospital of Liaoning Province, Shenyang, China
Objectives: The purpose of this meta-analysis is to assess whether there is an association between headache disorders and all-cause dementia, Alzheimer's disease (AD), and vascular dementia (VaD).
Methods: PubMed, Cochrane Library, Embase, and Web of Science were searched for cohort studies published from database inception to October 8, 2021, using medical subject headings (MeSH) and keywords. All statistical analyses were performed using Stata statistical software version 14.0. If P > 0.1 and I2 ≤ 50%, a fixed-effects model was adopted. If I2 > 50% (which indicated great heterogeneity), a random-effects model was adopted. The funnel plot and Egger's test were used to evaluate publication bias.
Results: This meta-analysis included 12 cohort studies covering 465,358 individuals, which were published between 2001 and 2020. The pooling analysis shows that a history of any headache disorder is associated with an increased risk of all-cause dementia (OR = 1.35; 95% CI: 1.21–1.50; I2 = 81.6%, P < 0.001). The history of any headache was associated with an increased risk of AD (OR = 1.49; 95% CI: 1.08–2.05; I2 = 70.0%, P = 0.003) and VaD (OR = 1.72; 95% CI: 1.32–2.25; I2 = 0%, P < 0.001). In the subgroup analysis, females with a history of headache have a slightly higher risk of dementia than males (OR = 1.32; 95% CI: 1.16–1.51; I2 = 88.3%, P < 0.001) and the risk of dementia in the retrospective cohort was slightly higher than in the prospective cohort (OR = 1.38; 95% CI: 1.22–1.56; I2 = 83.4%, P < 0.001).
Conclusions: Our meta-analysis shows that any headache disorder increases the risk of all-cause dementia, AD, or VaD. These findings provide evidence that headache should be recognized as an independent risk factor for dementia, AD, or VaD.
Background
Dementia is a neurological disorder characterized by cognitive, behavioral, social, and emotional deterioration. It is a major public health problem in the world and has a high incidence rate (Van Der Steen et al., 2018). Although significant progress has been made in molecular neuroimaging, clinical pathology, and the development of biomarkers of dementia in the last decade, the results are slightly disappointing. Clinicians are still waiting for disease modification therapy of dementia (Gale et al., 2018). Therefore, if we can identify the risk factors associated with dementia early, the development of dementia might be prevented. A previous study has explored the risk factors of dementia, including age, gender, family history, rural residents, low educational level, marital status, smoking, hypertension, hyperlipidemia, diabetes, heart disease, and cerebrovascular disease (Jia et al., 2020). The impact of headache on dementia has not been noted.
Headaches (including migraine, tension headache, and drug overuse headache) are associated with a high incidence rate, low quality of life, low productivity, and high economic costs. A global disease burden study listed headache as the second largest cause of disability in the world. Among people aged 15–49, the incidence of migraine is the third highest (Saylor and Steiner, 2018). Migraine can be regarded as a high signal of white matter-related risk factors (Kruit et al., 2004). Patients with headache are more likely to have extensive white matter hyperintensity (WMH) than patients without headache (Honningsvåg et al., 2018). White matter hyperintensity may be associated with dementia. Therefore, we speculate that headache may be associated with an increased risk of dementia, and we systematically reviewed the existing population-based longitudinal evidence to determine the association between headache disorder and the risk of all-cause dementia, Alzheimer's disease (AD), or vascular dementia (VaD).
Methods
This meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Page et al., 2021). The protocol was pre-registered in the International Prospective Register of Systematic Reviews (PROSPERO) platform, and the approval number is CRD42021283921.
Data Sources and Searches
PubMed, Cochrane Library, Embase, and Web of Science were searched for cohort studies published from database inception to October 8, 2021. There were no language restrictions, and the search strategy combined the use of medical subject headings (MeSH) and keywords. The search terms included dementia, AD, VaD, headache, head pain, migraine, and cohort studies. The full search strategy of PubMed is included in Supplementary Table 1. The reference lists of included cohort studies and other published meta-analyses were also examined to identify relevant trials.
Eligibility Criteria
The trials were included on the basis of the following eligibility criteria: (1) cohort studies or nested case-control studies based on cohort trials; (2) investigations of the association of headache disorders with the risk of incident all-cause dementia, AD, or VaD. In this meta-analysis, “any headache” was defined as “patients who suffered from any type of primary headache in the past.” All-cause dementia was chosen as the primary outcome, AD, and VaD as the secondary outcomes.
Trials were excluded if they did not provide an odds ratio (OR) estimate with corresponding 95% confidence interval (CI). If more than one study reported data from the same cohort, we included the study with the longest follow-up or the largest number of participants. Furthermore, the following articles were also excluded: conference abstracts, study protocols, duplicate publications, and studies with no outcomes of interest.
Study Selection
Study selection was performed by two reviewers (HLQ and ZCY) who independently screened the literature based on the eligibility and exclusion criteria. Duplicate and irrelevant articles were first excluded according to their titles and abstracts. Thereafter, the full texts of the potentially eligible articles were downloaded and read to identify all eligible studies. Any disagreements were resolved by the third reviewer (SDY), who acted as an arbiter.
Data Extraction
Data extraction was performed independently by the two above-mentioned reviewers (HLQ and ZCY) who consulted the guidelines on data extraction for systematic reviews and meta-analysis (Taylor et al., 2021). They used predesigned forms for extracting data including the first author, year of publication, study type, sample size, follow-up years, age, diagnosis of migraine/dementia, headache type, dementia type, and confounders adjusted. Disagreements were resolved by discussion with SDY to reach a consensus.
Risk of Bias Assessment
The Newcastle-Ottawa scale (NOS) was used to assess the quality of cohort studies (Wells et al., 2014). Stars ranged from 0 to 9 points for cohort studies, four stars for selection of participants and measurement of exposure, two stars for comparability, and three stars for assessment of outcomes and adequacy of follow-up, with more stars indicating higher quality of study. Scores of 0–3, 4–6, and 7–9 were considered to indicated low, moderate, and high quality, respectively.
Statistical Analysis
The adjusted OR and 95% CI from each trial were used to assess the association between headache disorders and risk of dementia, AD, or VaD. The χ2-test and the I2-values were used to evaluate heterogeneity. If P > 0.1 and I2 ≤ 50%, a fixed-effects model was adopted. If I2 > 50% (which indicated great heterogeneity), a random-effects model was adopted. The sensitivity analysis was performed by excluding one study each time and rerunning to verify the robustness of the overall effects. The funnel plot was visually inspected to confirm publication bias, and Egger's regression test was used to statistically assess publication bias. We conducted a subgroup analysis based on gender and research type. All statistical analyses were performed using Stata statistical software version 14.0 (Stata Corp, College Station, Texas).
Results
Literature Search
The systematic search of cohort studies published before October 8, 2021, identified 1,176 results. After title and abstract screening, 20 articles were considered potentially relevant. Twelve studies (Tyas et al., 2001; Chuang et al., 2013; Hagen et al., 2014; Røttereng et al., 2015; Yang et al., 2016; Tzeng et al., 2017; Yin et al., 2018; Kostev et al., 2019; Lee et al., 2019; Morton et al., 2019; George et al., 2020; Islamoska et al., 2020) were included after full text review, of which 11 reported the incidence of dementia or composite of AD or VaD on follow-up, and one study (Tyas et al., 2001) reported the incidence of AD only. The selection process is presented in Figure 1.
Figure 1. Studies screening process.
Study Characteristics
This meta-analysis included 12 cohort studies covering 465,358 individuals, which were published between 2001 and 2020. Four studies were retrospective cohort studies, while the other eight were prospective cohort studies. All individuals in these cohorts were at least 20 years old at the beginning of follow-up, and had clear diagnostic criteria for dementia. The average follow-up time ranged from 5 to 22 years. The adjusted estimates were available for almost all studies even though the adjusted confounders are slightly different. The main characteristics of the included trials are shown in Table 1.
Table 1. Basic characteristics of the included studies.
Quality Assessment
According to NOS criteria, the average score was 7.67 of all included cohort studies, and the score for each trail was 7 or above, indicating that all cohort studies were of high quality in this meta-analysis. The scores of the included studies are shown in Table 1.
Any Headache Disorders and Risk of All-Cause Dementia
Eleven cohort studies (Chuang et al., 2013; Hagen et al., 2014; Røttereng et al., 2015; Yang et al., 2016; Tzeng et al., 2017; Yin et al., 2018; Kostev et al., 2019; Lee et al., 2019; Morton et al., 2019; George et al., 2020; Islamoska et al., 2020) explored the association between a history of headache and the risk of all-cause dementia. The pooling analysis shows that a history of any headache disorder is associated with an increased risk of all-cause dementia (OR = 1.35; 95% CI: 1.21–1.50; I2 = 81.6%, P < 0.001; Figure 2). Sensitivity analysis showed that none of the individual studies reversed the pooled-effect size, which means that the results are robust (Supplementary Figure A).
Figure 2. Meta-analysis of the risk of all-cause dementia caused by any headache.
Any Headache Disorders and Risk of AD
Seven included studies (Tyas et al., 2001; Hagen et al., 2014; Røttereng et al., 2015; Yang et al., 2016; Yin et al., 2018; Kostev et al., 2019; Morton et al., 2019) assessed the association between any headache and the risk of AD. Overall, the history of any headache was associated with an increased risk of AD (OR = 1.49; 95% CI: 1.08–2.05; I2 = 70.0%, P = 0.003; Figure 3). Sensitivity analysis showed that none of the individual studies had reversed the pooled-effect size, which means that the results are robust (Supplementary Figure B).
Figure 3. Meta-analysis of the risk of Alzheimer's disease caused by any headache.
Any Headache Disorders and Risk of VaD
Five studies (Hagen et al., 2014; Røttereng et al., 2015; Yin et al., 2018; Kostev et al., 2019; Morton et al., 2019) assessed the association between a history of headache and the risk of VaD. Pooled results showed that a history of any headache disorder is associated with an increased risk of VaD (OR = 1.72; 95% CI: 1.32–2.25; I2 = 0%, P < 0.001; Figure 4).
Figure 4. Meta-analysis of the risk of vascular dementia caused by any headache.
Subgroup Analysis
We conducted a subgroup analysis of gender and research type, but still did not find the origin of the high heterogeneity. In the subgroup analysis, females with a history of headaches have a slightly higher risk of dementia than males; in the prospective cohort design, there is no direct relationship between the history of headaches and the increased risk of dementia. Meanwhile, a history of migraine is associated with a higher risk of dementia (OR = 1.32; 95% CI: 1.13–1.40; I2 = 75.6%, P < 0.001), but the risk is lower than that of non-migraine headache patients (Table 2).
Table 2. Subgroup analysis for the risk of dementia in patients with headache.
Publication Bias
A visual inspection of the funnel plot showed no evidence of a significant publication bias in the outcome of any headache disorders and risk of all-cause dementia (Figure 5). Egger's regression test (P = 0.087) likewise indicated no publication bias in our meta-analysis.
Figure 5. Publication bias of the risk of all-cause dementia caused by any headache.
Discussion
Main Findings
This meta-analysis included 12 cohort studies covering 465,358 individuals, which provided a comprehensive evaluation on the association between headache and dementia. We found a significant increase in the risk of all-cause dementia, AD, or VaD among individuals with headache, with an overall 1.35-fold, 1.49-fold, or 1.72-fold increase in risk, respectively, compared with non-headache controls. This indicates that headache might be an independent risk factor for dementia.
Interpretation of Findings
A previous review investigated the relationship between headache and dementia (Wang et al., 2018). The results showed that any headache increased the risk of all-cause dementia. However, it does not mean that headache is associated with an increased risk of all types of dementia. Moreover, it did not find a relationship between any headache and AD. In contrast, in the current analysis, we added more recent studies and analyzed the data according to the type and subgroup of dementia, so as to provide strong evidence for the association between headache and all-cause dementia, AD, or VaD. Another meta-analysis revealed that migraine is a potential risk indicator for AD and all-cause dementia (Wang et al., 2021). However, they did not find any association between migraine and the risk of VaD, which may be reasonably associated with the low number of studies included in their meta-analysis. Only five published cohort studies were identified in the review mentioned above. So, we re-analyzed the relationship between any type of headache and all-cause dementia, AD, or VaD. Our study found that any type of headache increases the risk of all-cause dementia, AD, or VaD, and the previous meta-analysis did not show these meaningful conclusions.
So far, there are few studies on the pathophysiological mechanism of the association between headache and dementia. Several brain structures involved in the pain network, such as the thalamus, insula, anterior cingulate gyrus, amygdala, and temporal cortex, also play an important role in the memory network (Apkarian et al., 2005; Svoboda et al., 2006). The overlap of the pain and memory network regions explains the potential correlation between chronic pain and memory impairment in patients with headache. The changes of hippocampal function and structure may play an important role in the pathophysiology of migraine (Maleki et al., 2013). The hippocampus is involved in memory consolidation, spatial navigation, and the stress response. Migraine is a paroxysmal disease. Each attack is accompanied by or causes many physiological and emotional stressors. Therefore, migraine attack can be regarded as a repeated stressor, causing changes in hippocampal structure and function. Some research showed that WMH is associated with an increased risk of all-cause dementia and AD (Godin et al., 2008; Bos et al., 2018; Garnier-Crussard et al., 2020). However, only a few studies have investigated the changes of the white matter microstructure and structural connectivity in migraine patients. The pathophysiology of migraine-related WMH is still poorly understood. In the current study, chronic headache may change the network of white matter by changing the mode and number of connections, resulting in the destruction of network topology. Therefore, the brain structural network of migraine patients shows abnormal overall integration between different migraine-related brain circuits adapted to long-term pain (Liu et al., 2013). Therefore, the white matter fibers of migraine patients will have abnormal changes, which may be related to the occurrence of dementia. Migraine is an independent risk factor for ischemic stroke, which may be related to the pathogenesis of VaD (Paemeleire, 2009). Migraine patients are more likely to develop psychiatric diseases, such as depression (Breslau et al., 1994; Chen et al., 2012; Rammohan et al., 2019). In particular, early depression (or depressive symptoms) has been associated with a more than two-fold increase in the risk of dementia (Katon et al., 2015; Lin et al., 2017). The possible biological mechanisms linking depression with dementia include vascular disease, changes in glucocorticoid levels, hippocampal atrophy, increased amyloid β plaque deposition, inflammatory changes, and nerve growth factor deficiency (Byers and Yaffe, 2011). In other words, patients with depression have a higher risk of dementia (Rapp et al., 2006; Wint, 2011). The number of neuritic plaques and neurofibrillary tangles in the hippocampus of AD patients with major depressive disorder confirmed by neuropathology is higher than that of AD patients who have never had a major depressive disorder in their life (Ringman et al., 2008).
In the subgroup analysis, females with a history of headaches have a slightly higher risk of dementia than males. Female are significantly more susceptible to migraine. The role of sex hormone fluctuations in promoting migraine attacks is well-known. This may be related to female sex hormones and their physiological fluctuations, which may play a role in women's susceptibility to pain hypersensitivity (Gazerani et al., 2005). In most clinical studies, migraine patients show impaired cognitive function during the interictal period (Cady and Farmer, 2013). An apolipoprotein E (ApoE) genotype is equally common in men and women, but plays a stronger role in women (Rocca et al., 2014). Apolipoprotein E is positively correlated with headache (Miao et al., 2015), which may explain why females with a history of headaches have a slightly higher risk of dementia than males.
Implications and Limitations
Our meta-analysis summarizes the existing evidence of the association between a history of headache and the risk of all-cause dementia and shows that any headache is a risk factor for all-cause dementia. It suggests that we need to pay more attention to the dementia risk of headache patients, which is also conducive to the early identification of high-risk groups of dementia. Meanwhile, this study also has certain limitations. We only included cohort studies. This controls many confounders and hence the conclusion is reliable. Future studies can consider including case-control studies and cross-sectional studies to enrich the research types. Moreover, we did not include covariate analysis in this meta-analysis. However, the included cohort studies have controlled the adjusted confounders and thus have a well-controlled confounding bias, making the conclusions of this study reliable and facilitating translation to the clinic.
Conclusions
This meta-analysis suggests that any headache disorder increases the risk of all-cause dementia, AD, or VaD. However, more studies are still needed to confirm the pathophysiological mechanisms underlying this phenomenon. The results of our meta-analysis can be very useful in the development of new dementia prevention and treatment strategies.
Data Availability Statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.
Author Contributions
XS and HC conceived the study. HQ and ZY collected the data and drafted the manuscript. SY revised the manuscript and language. HQ conducted the subgroup analysis. All authors have read and approved the manuscript.
Funding
This study was supported by the Doctoral Research Start-Up Fund Project of Liaoning (No. 2019-BS-234) and the Young and Middle-Aged Scientific and Technological Innovation Talents Support Program of Shenyang (No. RC210374).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2022.804341/full#supplementary-material
References
Apkarian, A. V., Bushnell, M. C., Treede, R. D., and Zubieta, J. K. (2005). Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 9, 463–484. doi: 10.1016/j.ejpain.2004.11.001
Bos, D., Wolters, F. J., Darweesh, S. K., Vernooij, M. W., de Wolf, F., Ikram, M. A., et al. (2018). Cerebral small vessel disease and the risk of dementia: a systematic review and meta-analysis of population-based evidence. Alzheimers Dement. 14, 1482–1492. doi: 10.1016/j.jalz.2018.04.007
Breslau, N., Davis, G. C., Schultz, L. R., and Paterson, E. L. (1994). Migraine and major depression: a longitudinal study. Headache 34, 387–393. doi: 10.1111/j.1526-4610.1994.hed3407387.x
Byers, A. L., and Yaffe, K. (2011). Depression and risk of developing dementia. Nat. Rev. Neurol. 7, 323–331. doi: 10.1038/nrneurol.2011.60
Cady, R., and Farmer, K. (2013). Migraine and cognition. Headache 53, 587–588. doi: 10.1111/head.12059
Chen, Y. C., Tang, C. H., Ng, K., and Wang, S. J. (2012). Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J. Head. Pain 13, 311–319. doi: 10.1007/s10194-012-0447-4
Chuang, C. S., Lin, C. L., Lin, M. C., Sung, F. C., and Kao, C. H. (2013). Migraine and risk of dementia: a nationwide retrospective cohort study. Neuroepidemiology 41, 139–145. doi: 10.1159/000353559
Gale, S., Acar, D., and Daffner, K. (2018). Dementia. Am. J. Med. 131, 1161–1169. doi: 10.1016/j.amjmed.2018.01.022
Garnier-Crussard, A., Desestret, V., Cotton, F., Chetelat, G., and Krolak-Salmon, P. (2020). White matter hyperintensities in ageing: pathophysiology, associated cognitive disorders and prevention. Rev. Med. Int. 41, 475–484. doi: 10.1016/j.revmed.2020.02.009
Gazerani, P., Andersen, O. K., and Arendt-Nielsen, L. (2005). A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 118, 155–163. doi: 10.1016/j.pain.2005.08.009
George, K. M., Folsom, A. R., Sharrett, A. R., Mosley, T. H., Gottesman, R. F., Hamedani, A. G., et al. (2020). Migraine headache and risk of dementia in the atherosclerosis risk in communities neurocognitive study. Headache 60, 946–953. doi: 10.1111/head.13794
Godin, O., Dufouil, C., Maillard, P., Delcroix, N., Mazoyer, B., and Crivello, F., et al. (2008). White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol. Psychiatry. 63, 663–669. doi: 10.1016/j.biopsych.2007.09.006.
Hagen, K., Stordal, E., Linde, M., Steiner, T. J., Zwart, J.-A., and Stovner, L. J. (2014). Headache as a risk factor for dementia: a prospective population-based study. Cephalalgia 34, 327–335. doi: 10.1177/0333102413513181
Honningsvåg, L.-M., Håberg, A. K., Hagen, K., Kvistad, K. A., Stovner, L. J., and Linde, M. (2018). White matter hyperintensities and headache: a population-based imaging study (HUNT MRI). Cephalalgia 38, 1927–1939. doi: 10.1177/0333102418764891
Islamoska, S., Hansen, Å. M., Wang, H.-X., Garde, A. H., Andersen, P. K., Garde, E., et al. (2020). Mid-to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J. Head. Pain 21, 1–12. doi: 10.1186/s10194-020-01166-7
Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., et al. (2020). Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5, e661–e671. doi: 10.1016/S2468-2667(20)30185-7
Katon, W., Pedersen, H. S., Ribe, A. R., Fenger-Grøn, M., Davydow, D., Waldorff, F. B., et al. (2015). Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psych. 72, 612–619. doi: 10.1001/jamapsychiatry.2015.0082
Kostev, K., Bohlken, J., and Jacob, L. (2019). Association between migraine headaches and dementia in more than 7,400 patients followed in general practices in the United Kingdom. J. Alzheimers. Dis. 71, 353–360. doi: 10.3233/JAD-190581
Kruit, M. C., van Buchem, M. A., Hofman, P. A., Bakkers, J. T., Terwindt, G. M., Ferrari, M. D., et al. (2004). Migraine as a risk factor for subclinical brain lesions. JAMA 291, 427–434. doi: 10.1001/jama.291.4.427
Lee, S. Y., Lim, J. S., Oh, D. J., Kong, I. G., and Choi, H. G. (2019). Increased risk of neurodegenerative dementia in women with migraines: a nested case–control study using a national sample cohort. Medicine 98, e14467. doi: 10.1097/MD.0000000000014467
Lin, W. C., Hu, L. Y., Tsai, S. J., Yang, A. C., and Shen, C. C. (2017). Depression and the risk of vascular dementia: a population-based retrospective cohort study. Int. J. Geriatr. Psych. 32, 556–563. doi: 10.1002/gps.4493
Liu, J., Zhao, L., Nan, J., Li, G., Xiong, S., von Deneen, K. M., et al. (2013). The trade-off between wiring cost and network topology in white matter structural networks in health and migraine. Exp. Neurol. 248, 196–204. doi: 10.1016/j.expneurol.2013.04.012
Maleki, N., Becerra, L., Brawn, J., McEwen, B., Burstein, R., and Borsook, D. (2013). Common hippocampal structural and functional changes in migraine. Brain Struct. Funct. 218, 903–912. doi: 10.1007/s00429-012-0437-y
Miao, J., Wang, F., Zheng, W., and Zhuang, X. (2015). Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis. BMC Neurol. 15, 1–5. doi: 10.1186/s12883-015-0385-2
Morton, R. E., St. John, P. D., and Tyas, S. L. (2019). Migraine and the risk of all-cause dementia, Alzheimer's disease, and vascular dementia: a prospective cohort study in community-dwelling older adults. Int. J. Geriatr. Psychol. 34, 1667–1676. doi: 10.1002/gps.5180
Paemeleire, K. (2009). Brain lesions and cerebral functional impairment in migraine patients. J. Neurol. Sci. 283, 134–136. doi: 10.1016/j.jns.2009.02.333
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71. doi: 10.1136/bmj.n71
Rammohan, K., Mundayadan, S. M., Das, S., and Shaji, C. V. (2019). Migraine and mood disorders: prevalence, clinical correlations and disability. J. Neurosci. Rural Pract. 10, 28–33. doi: 10.4103/jnrp.jnrp_146_18
Rapp, M. A., Schnaider-Beeri, M., Grossman, H. T., Sano, M., Perl, D. P., Purohit, D. P., et al. (2006). Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gener. Psych. 63, 161–167. doi: 10.1001/archpsyc.63.2.161
Ringman, J. M., Romano, J. D., Medina, L. D., Rodriguez-Agudelo, Y., Schaffer, B., Varpetian, A., et al. (2008). Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers. Dement. Geriatr. Cogn. Disord. 25, 380–384. doi: 10.1159/000121986
Rocca, W. A., Mielke, M. M., Vemuri, P., and Miller, V. M. (2014). Sex and gender differences in the causes of dementia: a narrative review. Maturitas 79, 196–201. doi: 10.1016/j.maturitas.2014.05.008
Røttereng, A. K. S., Bosnes, O., Stordal, E., Zwart, J.-A., Linde, M., Stovner, L. J., et al. (2015). Headache as a predictor for dementia: the HUNT Study. J. Head. Pain 16, 1–7. doi: 10.1186/s10194-015-0573-x
Saylor, D., and Steiner, T. J. (2018). The global burden of headache. Semin. Neurol. 38, 182–190. doi: 10.1055/s-0038-1646946
Svoboda, E., McKinnon, M. C., and Levine, B. (2006). The functional neuroanatomy of autobiographical memory: a meta-analysis. Neuropsychologia 44, 2189–2208. doi: 10.1016/j.neuropsychologia.2006.05.023
Taylor, K. S., Mahtani, K. R., and Aronson, J. K. (2021). Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis. BMJ Evid. Based Med. 26, 88–90. doi: 10.1136/bmjebm-2020-111651
Tyas, S. L., Manfreda, J., Strain, L. A., and Montgomery, P. R. (2001). Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int. J. Epidemiol. 30, 590–597. doi: 10.1093/ije/30.3.590
Tzeng, N. S., Chung, C. H., Lin, F. H., Yeh, C. B., Huang, S. Y., Lu, R. B., et al. (2017). Headaches and risk of dementia. Am. J. Med. Sci. 353, 197–206. doi: 10.1016/j.amjms.2016.12.014
Van Der Steen, J. T., Smaling, H. J., Van Der Wouden, J. C., Bruinsma, M. S., Scholten, R. J., and Vink, A. C. (2018). Music-based therapeutic interventions for people with dementia. Cochrane Database. Syst. Rev. 5, CD003477. doi: 10.1002/14651858.CD003477.pub4
Wang, J., Xu, W., Sun, S., Yu, S., and Fan, L. (2018). Headache disorder and the risk of dementia: a systematic review and meta-analysis of cohort studies. J. Head. Pain 19, 1–8. doi: 10.1186/s10194-018-0925-4
Wang, L., Wu, J. C., Wang, F. Y., Chen, X., and Wang, Y. (2021). Meta-analysis of association between migraine and risk of dementia. Acta Neurol. Scand. 145, 87–93. doi: 10.1111/ane.13528
Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., et al. (2014). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Oxford. Available online at: http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf (accessed October 16, 2021).
Wint, D. (2011). Depression: a shared risk factor for cardiovascular and Alzheimer disease. Clevel. Clin. J. Med. 78, S44–46. doi: 10.3949/ccjm.78.s1.07
Yang, F. C., Lin, T. Y., Chen, H. J., Lee, J. T., Lin, C. C., and Kao, C. H. (2016). Increased risk of dementia in patients with tension-type headache: a nationwide retrospective population-based cohort study. PLoS ONE 11, e0156097. doi: 10.1371/journal.pone.0156097
Keywords: headache, dementia, Alzheimer's disease, vascular dementia, meta-analysis
Citation: Qu H, Yang S, Yao Z, Sun X and Chen H (2022) Association of Headache Disorders and the Risk of Dementia: Meta-Analysis of Cohort Studies. Front. Aging Neurosci. 14:804341. doi: 10.3389/fnagi.2022.804341
Received: 29 October 2021; Accepted: 19 January 2022;
Published: 11 February 2022.
Edited by:
Omar Yaxmehen Bello-Chavolla, Instituto Nacional de Geriatría, MexicoCopyright © 2022 Qu, Yang, Yao, Sun and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoyu Sun, MTM2NTQ5MDI0MjUmI3gwMDA0MDsxNjMuY29t; Huisheng Chen, Y2hzemgmI3gwMDA0MDthbGl5dW4uY29t